NRX Pharmaceuticals (NRXP) Stock: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$3.40
0.00 (0.00%)
â˛
5d:
-0.87%
30d:
+1.19%
90d:
-13.27%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NRXP is fairly priced but lacks strong directional signals. At -11.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NRXP is fairly priced but lacks strong directional signals. At -11.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.73
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.18
18.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $3.40, which is considered fair relative to its 30-day fair value range of $3.29 to $3.56. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.8) compared to its historical average (9.6). Remarkably, the market is currently pricing in an annual earnings decline of 11.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is showing sideways momentum. The price is currently testing key support at $3.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.25 (+1025.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRXP is showing sideways momentum. The price is currently testing key support at $3.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $38.25 (+1025.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.29 -
$3.56
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.7%
Protect Your Profits
Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1025.0% below Wall St target ($38.25)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.29 -
$3.56
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$0.51
(15.0%)
Support & Resistance Levels
Support Level
$3.32
Resistance Level
$3.68
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.80
Wall Street Target
$38.25
(+1025.0%)
Valuation Discount vs History
-11.0% cheaper
PE vs Historical
6.8 vs 9.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.0%
(market-implied from PE analysis)
1-Year Target
$3.06
(-10%)
2-Year Target
$2.75
(-19%)
3-Year Target
$2.48
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7â10)
$3.50
(+3%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.8 to 9.6
Stabilization Target:
$4.80
(+41.2%)
PE Expansion Potential:
+41.2%
Share & Embed Analysis
Last updated: September 13, 2026 8:51 AM ET
Data refreshes hourly during market hours. Next update: 9:51 AM
Data refreshes hourly during market hours. Next update: 9:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 53 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
